This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

This week at the UPC: Aug. 29-Sept. 4

By Charlotte Westphal and Douglas Clarke-Williams ( September 4, 2025, 17:27 GMT | Insight) -- This week at the Unified Patent Court Johnson & Johnson subsidiaries saw their bid for provision measures rejected, the court was unmoved by Seoul Viosys' straw man argument, and Huawei was ordered to put down a security payment over enforcement doubts. The UPC also upheld its position on costs when both parties are partially successful.This week the UPC handled two cases concerning late action on the part of patent holders. Johnson & Johnson subsidiaries Cilag and Ethicon saw their application for provisional measures against Rivolution dismissed after the court found that companies had been aware of Rivolution"s activity for months but had taken no action. And Centripetal had its application for a discretionary review of a prior decision by the Mannheim division rejected after the court determined that it had delayed its application....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login